Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial

Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial

(2020) Renaud Felten et al.   ANNALS OF THE RHEUMATIC DISEASES

Treatment of primary Sjögren’s syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity

(2019) Thomas Dörner et al.   ANNALS OF THE RHEUMATIC DISEASES

Placebo response in rheumatoid arthritis clinical trials

(2019) Katie Bechman et al.   JOURNAL OF RHEUMATOLOGY

B cells in the pathogenesis of primary Sjögren syndrome

(2018) Gaëtane Nocturne et al.   Nature Reviews Rheumatology

Primary Sjögren’s Syndrome

(2018) Xavier Mariette et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome

(2017) Simon J. Bowman et al.   Arthritis & Rheumatology

Examination of overall treatment effect and the proportion attributable to contextual effect in osteoarthritis: meta-analysis of randomised controlled trials

(2016) Kun Zou et al.   ANNALS OF THE RHEUMATIC DISEASES

New Treatment Guidelines for Sjögren's Disease

(2016) Frederick B. Vivino et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

A Meta-Analysis to Estimate the Placebo Effect in Randomized Controlled Trials in Juvenile Idiopathic Arthritis

(2016) Erkan Demirkaya et al.   Arthritis & Rheumatology

Multiple Roles for B-Lymphocytes in Sjogren’s Syndrome

(2016) Julian Ambrus et al.   Journal of Clinical Medicine

Treatment of Primary Sjögren Syndrome With Rituximab

(2014) Valérie Devauchelle-Pensec et al.   ANNALS OF INTERNAL MEDICINE

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)

(2014) Raphaèle Seror et al.   ANNALS OF THE RHEUMATIC DISEASES

Model-based dose finding under model uncertainty using general parametric models

(2013) José Pinheiro et al.   STATISTICS IN MEDICINE

Treatment of Primary Sjögren Syndrome

(2010) Manuel Ramos-Casals et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The safety and side effects of monoclonal antibodies

(2010) Trevor T. Hansel et al.   NATURE REVIEWS DRUG DISCOVERY

The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials

(2008) W Zhang et al.   ANNALS OF THE RHEUMATIC DISEASES